Selena Gomez has admitted to struggling after being “attacked” for gaining weight following her lupus diagnosis.
The chart-topping singer, 27, was diagnosed with lupus in 2015 and later underwent a kidney transplant due to complications from the autoimmune disease.
She said a combination of her medication and other “health issues” regularly affects her weight and admitted she “really noticed” when people commented on her body.
Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.